End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5,150 KRW | +0.19% | -0.77% | -10.59% |
2023 | Dong Sung Bio Pharm.Co.,Ltd. announced that it has received KRW 14 billion in funding | CI |
2023 | Dong Sung Bio Pharm.Co.,Ltd. announced that it expects to receive KRW 14 billion in funding | CI |
Sales 2012 | 84.46B 61.83M 84.55M | Sales 2013 * | - | Capitalization | 118B 86.2M 118M |
---|---|---|---|---|---|
Net income 2012 * | - | Net income 2013 * | - | EV / Sales 2012 | 0.8 x |
Net cash position 2012 * | - 0 0 | Net cash position 2013 * | - 0 0 | EV / Sales 2013 * | - |
P/E ratio 2012 * |
-
| P/E ratio 2013 * |
-
| Employees | 290 |
Yield 2012 * |
-
| Yield 2013 * |
-
| Free-Float | 66.36% |
1 day | +0.19% | ||
1 week | -0.77% | ||
Current month | -0.77% | ||
1 month | -1.72% | ||
3 months | -4.45% | ||
6 months | -16.12% | ||
Current year | -10.59% |
Managers | Title | Age | Since |
---|---|---|---|
Yang-Gu Lee
CEO | Chief Executive Officer | 62 | - |
Chan-Tae Ko
AUD | Comptroller/Controller/Auditor | 65 | - |
Bong-Rim Cho
PRN | Corporate Officer/Principal | 62 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Yang-Gu Lee
CEO | Chief Executive Officer | 62 | - |
Young-Ryul Lee
BRD | Director/Board Member | 66 | 19-03-28 |
Won-Gyoon Na
BRD | Director/Board Member | 38 | 22-03-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 7 M€ | +0.11% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 5,150 | +0.19% | 39,948 |
24-05-23 | 5,140 | -0.19% | 38,289 |
24-05-22 | 5,150 | -0.39% | 31,636 |
24-05-21 | 5,170 | -0.19% | 30,733 |
24-05-20 | 5,180 | -0.19% | 29,342 |
End-of-day quote Korea S.E., May 23, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-10.59% | 86.26M | |
+18.04% | 42.95B | |
+16.92% | 21.38B | |
+18.33% | 15.05B | |
+19.27% | 14.45B | |
+56.12% | 13.04B | |
-0.05% | 6.79B | |
-10.73% | 6.72B | |
-8.87% | 5.73B | |
+11.21% | 5.47B |
- Stock Market
- Equities
- A002210 Stock